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Background: Dietary interventions during pregnancy alter offspring fitness. We have shown mouse maternal low protein
diet fed exclusively for the preimplantation period (Emb-LPD) before return to normal protein diet (NPD) for the rest of
gestation, is sufficient to cause adult offspring cardiovascular and metabolic disease. Moreover, Emb-LPD blastocysts sense
altered nutrition within the uterus and activate compensatory cellular responses including stimulated endocytosis within
extra-embryonic trophectoderm and primitive endoderm (PE) lineages to protect fetal growth rate. However, these
responses associate with later disease. Here, we investigate epigenetic mechanisms underlying nutritional programming
of PE that may contribute to its altered phenotype, stabilised during subsequent development. We use embryonic stem
(ES) cell lines established previously from Emb-LPD and NPD blastocysts that were differentiated into embryoid bodies
(EBs) with outer PE-like layer.
Results: Emb-LPD EBs grow to a larger size than NPD EBs and express reduced Gata6 transcription factor (regulator of PE
differentiation) at mRNA and protein levels, similar to Emb-LPD PE derivative visceral yolk sac tissue in vivo in later gestation.
We analysed histone modifications at the Gata6 promoter in Emb-LPD EBs using chromatin immunoprecipitation assay.
We found significant reduction in histone H3 and H4 acetylation and RNA polymerase II binding compared with NPD
EBs, all markers of reduced transcription. Other histone modifications, H3K4Me2, H3K9Me3 and H3K27Me3, were
unaltered. A similar but generally non-significant histone modification pattern was found on the Gata4 promoter.
Consistent with these changes, histone deacetylase Hdac-1, but not Hdac-3, gene expression was upregulated in
Emb-LPD EBs.
Conclusions: First, these data demonstrate ES cells and EBs retain and propagate nutritional programming adaptations
in vitro, suitable for molecular analysis of mechanisms, reducing animal use. Second, they reveal maternal diet induces
persistent changes in histone modifications to regulate Gata6 expression and PE growth and differentiation that may
affect lifetime health.
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Periconceptional environment, especially during oocyte
maturation and preimplantation development, can influ-
ence the pattern of later gestation leading to permanent
changes in offspring growth, physiology, health and dis-
ease risk through to adulthood [1-3]. Factors such as the
quality and composition of maternal or paternal diet, par-
ental metabolism and health, or specific conditions as used
in assisted conception such as embryo culture, can all in-
fluence the developmental programme. This sensitive win-
dow in the lifecycle around conception can be viewed
within the broader context of the Developmental Origins
of Health and Disease (DOHaD) concept. This proposes
that risk of adult onset diseases may derive from in utero
conditions where nutrient availability may control fetal
growth and metabolic homeostasis but which may predis-
pose to adult disease, particularly cardiovascular dysfunc-
tion and metabolic syndrome, if homeostatic changes do
not match postnatal environment. Epidemiological studies
on human populations and various animal models show
support for the DOHaD concept [4-7].
We have used a rodent maternal low protein diet model
to study mechanisms of periconceptional programming
whereby protein restriction is applied exclusively during
the period from mating to blastocyst formation (Emb-
LPD, 9% casein, E0-3.5 in mouse) with normal nutrition
(NPD, 18% casein) provided for the remainder of gesta-
tion, and standard chow diet postnatally. This brief nut-
ritional challenge is sufficient to induce cardiometabolic
dysfunction, hypertension and abnormal behaviour in
adulthood [8,9]. Emb-LPD changes the pattern of develop-
ment by altering the composition of the uterine fluid
which is detected by blastocysts via mTOR signalling [10].
The embryo responds to the nutrient challenge by
activating several compensatory processes within extra-
embryonic lineages which collectively act to increase
nutrient provision from the mother for the remainder of
gestation to protect fetal growth. These responses
include increased endocytosis and proliferation within
the trophectoderm lineage (TE; progenitor of chorio-
allantoic placenta) and increased motility and invasiveness
of outgrowing trophoblast at the time of implantation
[10,11]. LPD treatment maintained throughout gestation
leads to increased nutrient transport efficiency in the mid-
and late-gestation placenta [12]. Stimulated endocytosis is
also seen in response to Emb-LPD in the primitive en-
doderm (PE) extra-embryonic lineage formed from the
blastocyst inner cell mass (ICM); this response is main-
tained until late gestation within the derivative visceral
endoderm of the yolk sac placenta to promote nutrient
uptake from the uterine milieu [9,11]. Nutrient provision
and growth promotion resulting from these extra-
embryonic adaptations to poor maternal diet, whilst likely
favouring competitive fitness of offspring during periodsof limited food supply, also lead to later chronic disease
when the diet improves, evidenced by the resulting peri-
natal weight correlating with adult CV and behavioural
dysfunction [9].
Since extra-embryonic responses to Emb-LPD persist
from early development throughout gestation and have
important consequences for protecting conceptus growth
and affecting adult disease risk, we anticipate conserved
epigenetic mechanisms may be driving these physiological
processes. Moreover, the compensatory changes persist
well beyond the period of dietary challenge and reflect a
‘memory’ of an earlier environment. Periconceptional in-
duction of epigenetic change has been demonstrated in
other models of programming, such as following in vitro
culture treatment of pre-implantation embryos [13-17].
However, clear evidence of epigenetic modifications driv-
ing physiological responses within an in vivo periconcep-
tional programming model has not been forthcoming
previously.
Here, we investigate the epigenetic status of histone
modifications occurring within the PE lineage in re-
sponse to Emb-LPD for evidence of the programming of
altered phenotype. We have used embryoid bodies (EBs)
derived from embryonic stem (ES) cell lines generated
from Emb-LPD and NPD blastocysts since the PE-like
layer on the surface of Emb-LPD EBs exhibit the en-
hanced endocytosis compensatory phenotype after at
least six passages in standard culture [11].
Results
Effect of maternal diet on EB size
ES cells derived from blastocysts collected from Emb-
LPD and NPD females were maintained from passage 6
for 5.5 days in culture for EB formation in 96-well low
adhesion plate culture. At this time point, EBs have
formed primitive endoderm-like (PE) layer on their sur-
face as demonstrated by the presence of Gata6 and Dab2
marker proteins [11]. EBs were imaged and diameters
measured. EBs differentiated from Emb-LPD ES cells
were significantly larger (~15%; p < 0.05) than NPD EBs
(Figure 1).
Effect of maternal diet on embryoid body Gata factor
expression
The PE lineage is regulated through Gata6 and Gata4
transcription factors that activate PE specification and
differentiation through several downstream target genes
[18-21]. We investigated the expression of Gata4 and
Gata6 and the downstream target gene, Dab2 in Emb-
LPD and NPD EBs. Gata6 gene expression was signifi-
cantly reduced in Emb-LPD EBs while Gata4 was reduced
but only to trend level and Dab2 expression was un-
affected by maternal dietary origin (Figure 2A). Reduced
protein expression of Gata6 but not Dab2 was also evident
Figure 1 Embryoid bodies formed from ES cell lines derived
from Emb-LPD blastocysts grow to a larger size that those from
NPD blastocysts. (A) Embryoid body size at day 5.5 culture
measured by diameter, presented as mean ± upper and lower
quartiles (box) and SEM (vertical lines). Data from 6 cell lines as
biological replicates per treatment with 5 embryoid bodies
measured per replicate (ie, 30 per treatment); each rounded EB was
measured twice at orthogonal positions and the mean recorded.
(B) Representative images of NPD and Emb-LPD EBs. *p < 0.05.
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changed Gata6 expression in Emb-LPD EBs was sup-
ported by ex vivo analysis of mouse E17 visceral yolk sac
tissue also showing reduced Gata6 protein expression
compared with NPD control (Figure 2C).
Effect of maternal diet on Gata6 promoter histone
acetylation in embryoid bodies
Histone modifications have been shown to regulate
Gata4 and Gata6 gene expression in other models
[22,23]. We used ChIP assay to examine three upstream
regions of the Gata4 and Gata6 genes (Figure 3A) in
EBs to compare levels of histone modifications within
promoter domains with respect to maternal diet. A
panel of antibodies was used to probe histone acetylation
and methylation with targets for acetylated H3 and H4,
H3K4Me3, H3K4Me2, H3K9Me3 and H3K27Me3. Our
analysis revealed a distinct pattern of modifications
dependent upon dietary origin of EBs. The Gata6 pro-
moter at G6P1 site in Emb-LPD EBs exhibited signifi-
cant hypoacetylation of both H3 and H4 and a trend ofdecrease in the density of the histone marker H3K4Me3
compared with NPD EBs (Figure 3B). In addition to these
three histone modification changes known to be associated
with reduced gene expression [24], the G6P1 Gata6 pro-
moter site in Emb-LPD EBs had reduced enrichment of
RNA polymerase II (Figure 3B), further supporting a sup-
pressed state of expression. No significant changes in other
histone modifications, including H3K4Me2, H3K9Me3
and H3K27Me3, were detected. The Gata4 promoter site
at G4P1 showed a pattern of histone modifications in
Emb-LPD EBs similar to those in the Gata6 promoter but
not to the level of significance except that H3K9Me3 was
significantly reduced compared with NPD EBs (Figure 3C).
At other sites upstream of the Gata6 and Gata4 promoter
domains (G6P3, G6P5, G4P3, G4P5), maternal diet had lit-
tle or no effects on histone modifications (Figure 4A-D);
however, H3K4Me3 on G4P3 showed a significant increase
in Emb-LPD EBs (Figure 4C). We used Gapdh as a control
house-keeping gene in our ChIP analysis and found no dif-
ference in histone modifications on its promoter in EBs
with respect to maternal diet (Figure 4E).
Effect of maternal diet on expression of histone
deacetylases in embryoid bodies
Given the pattern of histone hypoacetylation detected at
the Gata6 promoter coinciding with reduced expression
of this gene in Emb-LPD EBs, we evaluated whether the
expression of histone deacetylases (HDACs) was altered
in response to maternal diet. HDACs are expressed in
early embryos and have been shown to modify their ex-
pression in response to in vitro culture [25]. We found
Hdac-1 gene expression but not Hdac-3 was upregulated
in Emb-LPD EBs (Figure 5).
Discussion
In this study we have investigated the molecular mecha-
nisms of developmental programming of the PE extra-
embryonic lineage within our Emb-LPD mouse model
associated with adult-onset disease. The Emb-LPD PE
shows enhanced endocytosis at ligand, lysosomal and re-
ceptor levels, a cellular modification that is sustained
through to late gestation in the yolk sac visceral endo-
derm to support increased nutrient uptake despite poor
maternal nutrition, thereby likely to protect fetal devel-
opment [9,11]. Significantly, these changes are main-
tained after induction even if maternal diet is returned
to control levels, a characteristic we have demonstrated
also occurs in the trophectoderm (TE) extra-embryonic
lineage [10,11] and is suggestive of epigenetic mecha-
nisms, the focus of the current study. We chose to in-
vestigate potential PE epigenetic mechanisms using EBs
since they maintain the enhanced endocytosis cellular
phenotype induced by nutritional programming previ-
ously revealed from ex vivo tissues [9,11] and, in the
Figure 2 Gata factor expression in embryoid bodies (EBs) at day 5.5 culture and in ex vivo visceral yolk sac (VYS) at E17.5 in relation
to maternal diet. (A) Expression of Gata4, Gata6 and Dab2 mRNA in EBs of Emb-LPD and NPD groups presented as ratio to the geometric mean
of Gapdh and Ppib transcripts (n = 5 per treatment). (B) Expression of Gata6 and Dab2 protein in EBs from NPD and Emb-LPD groups (n = 6 cell
lines per treatment). Upper: representative images of protein immunoblot bands. Lower: band intensity normalized to α-tubulin expression.
(C) Expression of Gata6 protein in VYS from Emb-LPD, LPD and NPD group (n = 4 samples per treatment). Upper: representative images of protein
immunoblot bands. Lower: band intensity normalized to α-tubulin expression. Values presented are mean ± SEM. *p < 0.05.
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seen in ex vivo VYS, thereby confirming their authenti-
city. Also, the PE-like layer formed on EBs from undif-
ferentiated ES cells is representative of the PE layer
formed in the late blastocyst from the ICM, and PE-like
cells in EBs as well as the core primitive ectoderm have
been used extensively as a model for early cell lineage
derivation in post-implantation development over many
years [26,27].
Our results show significant change in gene expression
and histone modifications in Emb-LPD EBs in comparison
with NPD EBs. Emb-LPD EBs express reduced levels of
Gata6 transcription factor, a key regulator of PE differenti-
ation [18,19], consistent with Gata6 downregulation foundin vivo within the Emb-LPD VYS. Reduced Gata6 expres-
sion coincided with histone H3 and H4 hypoacetylation
and reduced recruitment of RNA polymerase II at the
Gata6 promoter in Emb-LPD EBs, all factors consistent
with reduced gene expression [24]. Moreover, the expres-
sion of Hdac-1 but not Hdac-3 was increased in Emb-
LPD EBs. These HDACs are known to be expressed in
early embryos and are sensitive to culture conditions so
represent good candidates for coordinating histone epi-
genetic programming [25]. Collectively, these data reveal
for the first time a persistent change in EB epigenetic sta-
tus mediated through maternal diet and provide new clues
to the origin of developmental programming mechanisms














































Figure 3 ChIP analysis of histone modifications at Gata factor G6P1 and G4P1 promoter loci in EBs in relation to maternal diet. (A) The
Gata4 gene 5’ region is illustrated with three regions 5’ of exon 1 amplified by G4P1, G4P3 and G4P5. The Gata6 gene 5’ region is illustrated with
three regions amplified by G6P1, G6P3 and G6P5. (B, C) ChIP analysis was performed using antibodies to H3Ac, H4Ac, H3K4Me3, H3K4Me2,
H3K9Me3 H3K27Me3 and RNA Polymerase II and quantified by real-time PCR amplifying the G6P1 (B) and G4P1 (C) loci with results presented as
fold enrichment over IgG. Duplicates of ChIP experiments were performed throughout for verification. Values are means from 6 cell lines from
each diet group with standard errors represented by vertical bars, *p < 0.05, # < 0.1.
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long after the inductive dietary challenge, and provide a
useful tool for analysis of underlying mechanisms, redu-
cing the requirement for experimental animals.
The finding that Emb-LPD EBs, and ex vivo VYS, ex-
hibit reduced Gata6 expression, apparently regulated
through histone hypoacetylation in the EBs, may explain
the increased size of Emb-LPD EBs. Gata6 and Gata4are zinc-finger transcription factors that perform mul-
tiple roles both during development in the determin-
ation of cell lineages and in adult tissues in maintaining
cell differentiation states [28,29]. Loss of Gata factor ex-
pression has been implicated in several forms of cancer
and in ovarian cancer models where loss of Gata6 and
Gata4 expression coincides with Gata6 and Gata4 pro-















































































































Figure 4 ChIP analysis of histone modifications at Gata factor G6P3, G6P5, G4P3 and G4P5 promoter loci in EBs in relation to maternal
diet. (A-D) ChIP analysis was performed using antibodies H3Ac, H4Ac, H3K4Me3 and RNA polymerase II and quantified by real-time PCR amplifying the
G6P3 (A), G6P5 (B), G4P3 (C) and G4P5 (D) loci with results presented as fold enrichment. (E) ChIP analysis was performed using antibodies H3Ac, H4Ac,
H3K4Me3, H3K4Me2, H3K9Me3 H3K27Me3 and RNA Polymerase II and quantified by real-time PCR amplifying the Gapdh promoter with results presented
as fold enrichment over IgG. Duplicates of ChIP experiments were performed throughout for verification. Values are means for 6 cell lines from each diet
group with standard errors represented by vertical bars, *p < 0.05, # < 0.1.
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[23,30,31] indicating a similarity in epigenetic and cellu-
lar mechanisms to the current study.
Whilst Emb-LPD EBs had downregulated Gata6 ex-
pression, Gata4 expression was not significantly affected.
In ES cells, absence of Gata6 gene leads to loss of Gata4
expression whilst absence of Gata4 gene does not inhibit
Gata6 expression, indicating a hierarchical relationship
[21,32,33]. However, functional redundancy exists be-
tween Gata6 and Gata4 expression in other modelsincluding pancreatic and ovarian germ cell differenti-
ation and in EBs during myocyte differentiation with
Gata4 expression not dependent upon Gata6 expression
[34-36]. Thus, the distinction between Gata6 and Gata4
expression in the current study may be explained either by
functional redundancy or by Gata6 expression, although
reduced, being above the threshold required for Gata4
expression.
The Emb-LPD EBs also showed expression of the Gata6






























Figure 5 Gene expression of histone modification enzymic
regulators Hdac-1 and Hdac-3 in embryoid bodies (EBs) at day
5.5 culture in relation to maternal diet. Expression presented as
ratio to the geometric mean of Gapdh and Ppib transcripts. (n = 5
per treatment). *p < 0.05.
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Dab2 acts as a cargo-selective adaptor protein facilitating
apical localisation of the megalin receptor (Lrp2 gene) and
clathrin-mediated endocytosis [37]. The endocytic func-
tion in Emb-LPD EBs is stimulated together with in-
creased expression of megalin as a compensatory response
to maternal diet [11] and Dab2 expression and function is
likely protected in the EB model to achieve this. Dab2 ex-
pression may be maintained either by a Gata4-dependent
pathway [33,38], by Gata6 being above the threshold re-
quired for Dab2 promoter activation or by an alternative
mechanism. We anticipate that the growth stimulation co-
inciding with reduced expression of Gata6 but not Dab2
in Emb-LPD EBs will be partly driven by the increased nu-
trient delivery provided by enhanced endocytosis. The
resulting increase in growth in Emb-LPD EBs may extend
to both surface PE-like layer and core epiblast cells and,
like other compensatory response mechanisms, may re-
flect in vivo processes that safeguard fetal development
against dietary deficiency. Indeed, the increased endocytic
activity observed within the mature VYS in late gestation
may be dependent upon this initial growth stimulation.Conclusions
We have shown that maternal diet regulates the epigen-
etic status of the early embryo, reducing expression of
the PE lineage regulator, Gata6 transcription factor, in
EBs. Reduced Gata6 gene expression coincides with
histone hypoacetylation and loss of RNA polymerase
binding of the Gata6 promoter, and stimulation of Hdac-1
expression. These changes are associated with increased
growth of the Emb-LPD EB which may contribute, along-
side stimulation in endocytosis, as compensatory re-
sponses to support maintenance of nutrient delivery.Methods
Ethics statement
All animal research was conducted under UK Home Of-
fice project license and local ethics approval (University
of Southampton).
Animals, diet treatment and embryo collection
MF1 mice were bred in-house (University of Southampton
Biomedical Research Facility) on a 0700–1900 light cycle
with standard chow, under UK Home Office license and
local ethics approval. Virgin females (7–8.5 weeks) were
mated naturally overnight with MF1 males and plug posi-
tive females were housed individually the following morn-
ing and assigned randomly to either normal protein diet
(18% casein, NPD) or isocaloric low protein diet (9% ca-
sein, Emb-LPD) until embryonic day 3.5 (E3.5); diet com-
position has been described elsewhere [8,9]. Embryos were
collected at the blastocyst stage after cervical dislocation
and uterine flushing with H6 medium with 4 mg/ml BSA
(H6 + BSA) [39].
ES cell culture and embryoid body (EB) formation
Mouse embryonic stem (ES) cell lines were prepared
using standard procedures from blastocysts derived
from mothers fed NPD or Emb-LPD upon culture in
knockout-Dulbecco’s modified Eagle medium [high glu-
cose] (DMEM [high glucose], Gibco).
including 20% knock out serum replacement (Gibco)
with other supplements and were subsequently main-
tained and expanded on mouse embryonic fibroblast
feeder layers up to passage 5–7 as described in detail
elsewhere [11]. A total of 18 ES lines were generated
from Emb-LPD blastocysts and 38 lines from NPD blas-
tocysts. Six clones, each from a different mother and of
male gender and normal karyotype, from each diet treat-
ment were selected for use in the current study and
were used for all relevant experiments. For embryoid
body (EB) formation, ES cells were dissociated with
0.05% trypsin-EDTA and suspended in ES cell culture
medium without leukaemia inhibitory factor (LIF) sup-
plementation for 1 h on gelatin-treated dishes. A cell
suspension (4,000 in 200 μl) was subsequently pipetted
into low-adherence 96-well plates and statically incu-
bated at 37°C in humidified air with 5% CO2 for 5.5 days
to form individual EBs within each well using a method
previously described that is optimised for uniform EB
size production [11,40]. EB diameter at specific time in-
tervals was measured using an Olympus microscope
software and Cell sense®.
RNA isolation and real-time PCR
RNA isolation and quantitative real-time PCR (qRT-
PCR) of EBs and tissues was performed as described pre-
viously [41]. Briefly, total RNA was extracted from EBs
Table 2 Stability order of house-keeping genes in NPD
and Emb-LPD EBs selected by GeNorm and Normfinder
software
GeNorm Normfinder






Sun et al. BMC Developmental Biology  (2015) 15:3 Page 8 of 10and tissues using the RNeasy Mini kit (Qiagen, UK),
with on-column DNase digestion. RNA was quantified
using the Nanodrop ND-1000 spectrophotometer, and
cDNA generated using a random priming strategy and
the ImProm-II™ Reverse Transcription System (Promega,
UK). cDNA was diluted to a concentration equivalent to
5 ng RNA per μl and used at 1 μl in a reaction volume
of 20 μl with forward and reverse primers at final con-
centration of 300 nM each in qRT-PCR using the
Chromo4 Real-Time Detector (BioRad, UK) with Opticon
Monitor v3.1 software. Thermal cycling conditions were
95°C 10 min enzyme activation, then 40 cycles of 95°C for
15 s followed by 60°C for 1 min, with a final extension step
of 10 min at 72°C. Primers used for qRT-PCR were de-
signed by Primer3 software (Table 1). For EBs, Gapdh and
Ppib were selected from 6 house-keeping candidates with
GeNorm and NormFinder software for stability, showing
no change in expression between Emb-LPD and NPD
treatments (Table 2). For quantification, efficiency of
primers was determined by series 1/10 dilution and Ct
value. Efficiency was calculated as E = 101/slope and quali-
fied primer efficiency is between 1.9-2.1. Calculation of
relative expression of target gene was calculated as E^-dCt
then divided by the geometric mean of relative expression
of the reference gene pair.
Protein isolation and western blotting
Approximately 100 EBs on day 5.5 were washed with PBS
and lysed with 120 μl RIPA buffer (50 mM Tris–HClTable 1 Primers used in qRT-PCR and ChIP Q-PCR
Primer
name
Forward primer (5′-3′) Reverse perimer (5′-3′) Assay
Gata4 P1 gggctggtggaggttctc tcagtgcctagagacgcaag
ChIP Q-PCR
Gata4 P3 gccattctctgcattcatcc tcgctgagcatcaaggaac
Gata4 P5 tctgagaggagccgataacc gaactaggcgacctctgtgc
Gata6 P1 catttggagggagcgactaa tccaaggacgctagtttggt
Gata6 P3 agaacctggactgcgcttt tttgctgctccctcaatgta
















Ppar ccttccctgtgaactgacg ccacagagcgctaagctgt[pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
NP-40, 1% sodium deoxycholate, 1 mM Na3VO4, 50 mM
NaF, cOmplete EDTA-free protease inhibitor cocktail
(Roche), 0.5 mM PMSF). Lysate was sonicated on ice and
protein content detected using the BCA assay (Pierce).
20 μl protein was mixed with 4x LDS sample buffer and
DTT and boiled for 5 min before electrophoresis. After
electrophoresis, protein was transferred to polyvinylidene
fluoride membrane (0.45 μm) using wet transfer protocol.
This was followed by blocking with 5% milk in TBS and
incubation with primary antibody overnight at 4°C. The
next day the membrane was washed with TBST and incu-
bated with IRDye secondary antibody (Odyssey; 1:10,000)
for 1 hour, washed and imaged with the Licor western de-
tection system. Band intensity was quantified with Licor
software. Antibodies used are shown in Table 3. α-tubulin
was used as loading control and did not change in expres-
sion with respect to dietary treatment (data not shown).
Chromatin immunoprecipitation (ChIP)
A modified protocol was used to perform the Matrix
ChIP assay [42]. EBs were dissociated with trypsin EDTA
for 5 mins at 37°C, then serum was added to stop trypsi-
nisation and the sample passed through a 21 g needle toTable 3 Antibodies used in western blotting and ChIP
analyses
Antibody Source Code/dilution Technique
Gata6 R&D Systems AF1700, 1:100 westerns
Dab-2 BD Biosciences 610465, 1:1,000 westerns
α-tubulin Cell Signaling 2144, 1:500 westerns
H4Ac Millipore 06-866 ChIP
H3Ac Millipore 06-599 ChIP
H3K4Me3 Actif Motif 339916 ChIP
H3K4Me2 Actif Motif 339914 ChIP
H3K9Me3 Abcam ab8898 ChIP
H3K27Me3 Abcam ab6002 ChIP
RNA Polymerase II Abcam ab5408 ChIP
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cross-linked with 0.4% formaldehyde for 15 min at RT,
then quenched with 125 mM glycine. Cells were spun
down and resuspended in IP buffer (150 mM NaCl,
50 mM Tris–HCl pH 7.5, 5 mM EDTA pH 8, 0.5% NP-
40, 0.5% Triton-X-100) supplemented with proteinase
and phosphatase inhibitors (cOmplete EDTA-free pro-
tease inhibitor cocktail, Roche; Phosphatase Inhibitor
Cocktail 2 and 3, Sigma) added to suspension (200 μl
per 1x106 cells) and incubated on ice for 5 mins before
centrifugation at 10,000 rpm for 3 mins at 4°C to obtain
nuclei-enriched pellet. Pellets were suspended in the
same amount of IP buffer with proteinase inhibitor
(200 μl per 1x106 cell nuclei). DNA was sheared on ice
with MSE Soniprep 150 (6 μA for 20 cycles of 30 s on/
60s off followed by 7.5 μA for 4 cycles of 10s on/ 30 s
off ). 96-well polypropylene PCR plates treated with UV-
C light for 2 days were used for ChIP. Each well was in-
cubated with 0.5 μg Protein A (Sigma) in 100 μl 1 × PBS
for 36 hours. On the day of use, each plate was washed
twice with 100 μl 1 × PBS, then blocked with 200 μl
blocking buffer (IP buffer with addition of 5% BSA and
100 μg/ml sheared salmon sperm DNA) for 30 mins,
RT. Wells were then incubated with 0.25 μg antibody
in 50 μl blocking buffer for 2 hours, RT. Chromatin
(equivalent of 5x104 cells per assay) was diluted to 50 μl
with blocking buffer, pre-incubated for 15 mins on ice
and then incubated in the wells for 2.5 hours at 4°C.
Wells were washed with 100 μl ice-cold IP buffer 7 times
and twice with 100 μl ice cold TE buffer (10 mM Tris,
1 mM EDTA; pH 7.6). Finally, 50 μl elution buffer
(0.1 mg/ml proteinase K, 25 mM Tris base, 1 mM
EDTA, pH 10) was added per well. 1/10th of the sample
chromatin in 50 μl of elution buffer was used as input.
Plates were incubated for 30 min at 55°C, followed by
10 min at 95°C in an ABI 7900HT thermocycler prior to
quantitative PCR (qPCR).
Antibodies used in ChIP are shown in Table 3. Each
qPCR reaction used 2 μl immunoprecipitated DNA. The
modified histone binding was expressed as fold enrich-
ment ratio to IgG negative control (Cell Signaling). Stan-
dards and samples were simultaneously amplified in 10 μl
reaction volume and primers were designed to amplify
genomic sequences at the 5′UTR of Gata4, Gata6 and
Gapdh genes (see Table 1).
Statistical analysis
Results were expressed as mean ± S.E.M. Comparison of
mRNA expression, histone modification or Western blot-
ting between control and treated groups was performed
by one way ANOVA or t-test. EB diameters were com-
pared across treatments using multilevel random effects
regression model (SPSS). Significance testing was set at
P < 0.05 (two-tailed).Abbreviations
ChIP: Chromatin immunoprecipitation; DOHaD: Developmental Origins of
Health and Disease; Emb-LPD: Embryo low protein diet; EB: Embryoid body;
ES: Embryonic stem cells; HDAC: Histone deacetylase; ICM: Inner cell mass;
NPD: Normal protein diet; PE: Primitive endoderm; TE: Trophectoderm;
VYS: Visceral yolk sac.
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